Hallett David — SEC Form 4 filings

SEC reporting owner CIK 2006495. 4 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2026-02-10 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
RECURSION PHARMACEUTICALS, INC. (RXRX)Chief Scientific Officer46

Form 4 filings — Hallett David

FiledFormIssuerReported transactionsSource
2026-08-184RECURSION PHARMACEUTICALS, INC. (RXRX)Tax withholding (F): 26,657 @ $3.16EDGAR
2026-05-194RECURSION PHARMACEUTICALS, INC. (RXRX)Tax withholding (F): 26,657 @ $3.04EDGAR
2026-02-194RECURSION PHARMACEUTICALS, INC. (RXRX)Tax withholding (F): 11,908 @ $3.49EDGAR
2026-02-104RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 502,064 @ $0 · Grant/award (A): 24,254 @ $0 · Tax withholding (F): 11,400 @ $3.98EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2006495 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →